Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Rosa Molaro"'
Autor:
Rosa Zampino, Domenico Iossa, Maria Paola Ursi, Lorenzo Bertolino, Roberto Andini, Rosa Molaro, Oriana Fabrazzo, Silvia Leonardi, Luigi Atripaldi, Emanuele Durante-Mangoni
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Infective endocarditis (IE) is a life-threatening disease whose prognosis is often difficult to predict based on clinical data. Biomarkers have been shown to favorably affect disease management in a number of cardiac disorders. Ai
Externí odkaz:
https://doaj.org/article/a908c24d123a4962b56234249103be5b
Autor:
Erasmo Falco, Fabiana D’Amico, Emanuele Durante-Mangoni, Irene Mattucci, M. Grimaldi, Rosa Zampino, Rosa Molaro, Domenico Iossa
Publikováno v:
Clinical Infection and Immunity. 6:75-81
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3b5761e6ff187ea92e650f610de5519
https://doi.org/10.14740/cii140
https://doi.org/10.14740/cii140
Autor:
Rosa Zampino, Domenico Iossa, Maria Paola Ursi, Lorenzo Bertolino, Arta Karruli, Rosa Molaro, Gennaro Esposito, Martina Vitrone, Fabiana D’Amico, Rosina Albisinni, Emanuele Durante-Mangoni, on behalf of the Monaldi Hospital CardiovascularInfection Group
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 5386, p 5386 (2021)
Journal of Clinical Medicine
Volume 10
Issue 22
Journal of Clinical Medicine
Volume 10
Issue 22
(1) Background: The aim of this study was to assess the clinical significance and prognostic role of the main hemostasis parameters in infective endocarditis (IE): prothrombin time as international normalized ratio (PT-INR), activated partial thrombo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2177579dd3f4b567ba6b3e1304beed70
https://www.mdpi.com/2077-0383/10/22/5386
https://www.mdpi.com/2077-0383/10/22/5386
Autor:
Maria Paola Ursi, Roberto Andini, Emanuele Durante-Mangoni, Luigi Atripaldi, Rosa Zampino, Domenico Iossa, Rosa Molaro, Silvia Leonardi, Oriana Fabrazzo, Lorenzo Bertolino
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
Background Infective endocarditis (IE) is a life-threatening disease whose prognosis is often difficult to predict based on clinical data. Biomarkers have been shown to favorably affect disease management in a number of cardiac disorders. Aims of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f75d271771b20d10ae59e6c5096e4a57
https://pubmed.ncbi.nlm.nih.gov/33413127
https://pubmed.ncbi.nlm.nih.gov/33413127
Autor:
Martina Vitrone, Emanuele Durante-Mangoni, Ciro Maiello, Domenico Iossa, Luca Rinaldi, Roberto Andini, Rosa Molaro, Pia Clara Pafundi, Rosa Zampino, Antonio Parrella, Enrico Ragone
Publikováno v:
Journal of Clinical Virology. 96:54-59
Background Occult hepatitis B infection consists of persistence of HBV genomes in hepatocytes,absence of serum HBsAg, low/undetectable serum HBVDNA. Reactivation of HBV infection may occur during immunosuppression, but few data are available in heart
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf335af358636b6a6782e0ad0a16f8b3
https://doi.org/10.1016/j.jcv.2017.09.011
https://doi.org/10.1016/j.jcv.2017.09.011
Autor:
Emanuele Durante-Mangoni, Antonio Parrella, Domenico Iossa, Carminia Battimelli, Pia Clara Pafundi, Erasmo Falco, Riccardo Utili, Rosa Molaro, Giuseppe Sodano
The classical pegylated interferon α (peg-IFNα) and ribavirin (RBV) treatment of chronic hepatitis C (CHC) is progressively being replaced by new direct acting antivirals, whose costs remain a major barrier to widespread use. Using baseline data an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f85c341040ebc7610365a351f513692
http://hdl.handle.net/11591/371229
http://hdl.handle.net/11591/371229
Autor:
Riccardo Utili, Domenico Iossa, Emanuele Durante-Mangoni, Federica Agrusta, Enrico Ragone, Daniela Di Pinto, Ciro Maiello, Maria Consiglio Grimaldi, Cristiano Amarelli, Rosa Molaro
Publikováno v:
Clinical Transplantation. 27:E282-E288
Chronic hepatitis B is prevalent in the transplant setting and may cause significant complications. Effective control of viral replication is needed. Besides lamivudine, very little data are available on safety and efficacy of other drugs. We describ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88a8cab8abfe063dba9a594fefbd39b2
https://doi.org/10.1111/ctr.12109
https://doi.org/10.1111/ctr.12109
Autor:
M. Grimaldi, Federica Agrusta, Domenico Iossa, Emanuele Durante-Mangoni, R. Casillo, Daniela Di Pinto, Roberto Andini, Riccardo Utili, Rosa Molaro
Background Cytomegalovirus (CMV) infection is a major complication of immunosuppression after heart transplant. Recent studies suggest the actual immunosuppressive regimen may affect the risk of CMV infection. Objectives To evaluate incidence, risk f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::117a93d6a6a21b8dbfa552fee64c638a
http://hdl.handle.net/11591/333511
http://hdl.handle.net/11591/333511
Autor:
Emanuele Durante-Mangoni, Domenico Iossa, Roberto Andini, Umberto Malgeri, Rosa Molaro, Riccardo Utili, Rosina Albisinni, Irene Mattucci
Publikováno v:
Internal and emergency medicine. 10(5)
The pathogenesis of infective endocarditis (IE) involves activation of the haemostasis system at the site of endocardial defects. Whether prothrombotic conditions are associated with IE by enhancing early vegetation formation is unknown. In this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5df6a74fa1f2b07b26e68308377bcd61
https://pubmed.ncbi.nlm.nih.gov/26033535
https://pubmed.ncbi.nlm.nih.gov/26033535
Autor:
Antonio Parrella, Riccardo Utili, Roberto Andini, Emanuele Durante-Mangoni, Carminia Battimelli, Rosa Molaro, Domenico Iossa, Giuseppe Sodano
Publikováno v:
Clinical drug investigation. 34(12)
Pegylated interferon (peg-IFN)-α2a and -α2b show different pharmacokinetic properties but are used interchangeably for hepatitis C treatment in traditional dual combinations and with newer agents. We assessed whether peg-IFN antiviral effects vary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afc41b50e4ee7973665c745f714c8de0
https://pubmed.ncbi.nlm.nih.gov/25349040
https://pubmed.ncbi.nlm.nih.gov/25349040